CLAZI XR 30 MG COM LIB PROL CT BL AL PVDC BCO LEIT X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1058309410034 -
GGREM
526119030106103 -
Código de barras
7896004752914 -
Código de barras
7896004775432
O que a fonte publica
- Detentor do registro
- GERMED FARMACEUTICA LTDA
- Princípios ativos
- GLICLAZIDA
- Embalagem
- 30 MG COM LIB PROL CT BL AL PVDC BCO LEIT X 60
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- A10H - ANTIDIABÉTICOS SULFONILOURÉIAS PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "CLAZI XR 30 MG COM LIB PROL CT BL AL PVDC BCO LEIT X 60",
"holder": "GERMED FARMACEUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896004752914",
"7896004775432"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526119030106103",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "45.992.062/0001-65",
"priceRegime": "Regulado",
"productName": "CLAZI XR",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "30 MG COM LIB PROL CT BL AL PVDC BCO LEIT X 60",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "64.78",
"icms-12": "73.61",
"icms-17": "78.05",
"icms-18": "79.00",
"icms-19": "79.98",
"icms-20": "80.98",
"icms-21": "82.00",
"icms-22": "83.05",
"icms-23": "84.13",
"icms-17.5": "78.52",
"icms-19.5": "80.47",
"icms-20.5": "81.48",
"icms-22.5": "83.59",
"icms-12-alc": "72.73",
"icms-17-alc": "77.11",
"icms-18-alc": "78.05",
"icms-19-alc": "79.02",
"icms-20-alc": "80.00",
"icms-21-alc": "81.02",
"icms-22-alc": "82.05",
"icms-23-alc": "83.12",
"withoutTaxes": "64.00",
"icms-17.5-alc": "77.58",
"icms-19.5-alc": "79.51",
"icms-20.5-alc": "80.51",
"icms-22.5-alc": "82.58"
},
"pisCofinsList": "Positiva",
"substanceText": "GLICLAZIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "89.29",
"icms-12": "101.46",
"icms-17": "107.58",
"icms-18": "108.89",
"icms-19": "110.24",
"icms-20": "111.62",
"icms-21": "113.03",
"icms-22": "114.48",
"icms-23": "115.96",
"icms-17.5": "108.23",
"icms-19.5": "110.92",
"icms-20.5": "112.31",
"icms-22.5": "115.22",
"icms-12-alc": "100.54",
"icms-17-alc": "106.60",
"icms-18-alc": "107.90",
"icms-19-alc": "109.24",
"icms-20-alc": "110.60",
"icms-21-alc": "112.01",
"icms-22-alc": "113.43",
"icms-23-alc": "114.91",
"withoutTaxes": "88.48",
"icms-17.5-alc": "107.25",
"icms-19.5-alc": "109.92",
"icms-20.5-alc": "111.30",
"icms-22.5-alc": "114.16"
},
"invalidBarcodes": [],
"activeSubstances": [
"GLICLAZIDA"
],
"therapeuticClass": "A10H - ANTIDIABÉTICOS SULFONILOURÉIAS PUROS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1058309410034",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10H",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526119030106103"